Literature DB >> 28186467

Effect of the Microenvironment on Mesenchymal Stem Cell Paracrine Signaling: Opportunities to Engineer the Therapeutic Effect.

Gina D Kusuma1, James Carthew1, Rebecca Lim2,3, Jessica E Frith1.   

Abstract

Cues from the extracellular environment, including physical stimuli, are well known to affect mesenchymal stem cell (MSC) properties in terms of proliferation and differentiation. Many therapeutic strategies are now targeting this knowledge to increase the efficacy of cell therapies, typically employed to repair tissue functions in the event of injury, either by direct engraftment into the target tissue or differentiation into mature tissues. However, it is now envisioned that harnessing the repertoire of factors secreted by MSCs (termed the secretome) may provide an alternate to these cell therapies. Of current interest are both direct protein secretions and two major subpopulations of bioactive extracellular vesicles (EVs), namely exosomes and microvesicles. EVs released by MSCs are reflective of their cells of origin, able to impact upon the activities of other cells in the local microenvironment, making the rational design of MSC paracrine activities an encouraging strategy to reproducibly modulate cell therapies. The precise mechanisms by which the secretome is modulated by the microenvironment, however, remain elusive. Controlling MSC growth conditions with oxygen tension, growth factor composition, and mechanical properties may serve to directly influence paracrine activity. Our growing understanding implicates components of the mechanotransduction machinery in translating both mechanical and chemical cues from the environment into alterations in gene regulation and varied paracrine activity. As technologies are developed to manufacture MSCs, advances in bioengineering and novel insight of how the extracellular environment affects MSC paracrine activity will play a pivotal role in the generation of widespread, successful, clinical MSC therapies.

Entities:  

Keywords:  exosomes; mesenchymal stem cell; microenvironment; paracrine signaling; tissue engineering

Mesh:

Year:  2017        PMID: 28186467     DOI: 10.1089/scd.2016.0349

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  109 in total

1.  Cell sheet biofabrication by co-administration of mesenchymal stem cells secretome and vitamin C on thermoresponsive polymer.

Authors:  Behnaz Banimohammad Shotorbani; Helder André; Abolfazl Barzegar; Nosratollah Zarghami; Roya Salehi; Effat Alizadeh
Journal:  J Mater Sci Mater Med       Date:  2018-11-03       Impact factor: 3.896

2.  Dynamic secretome of bone marrow-derived stromal cells reveals a cardioprotective biochemical cocktail.

Authors:  David D Ellison; Yasir Suhail; Junaid Afzal; Laura Woo; Onur Kilic; Jeffrey Spees; Andre Levchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-25       Impact factor: 11.205

Review 3.  Emergence of the Stem Cell Secretome in Regenerative Engineering.

Authors:  Leila Daneshmandi; Shiv Shah; Tahereh Jafari; Maumita Bhattacharjee; Deandra Momah; Nikoo Saveh-Shemshaki; Kevin W-H Lo; Cato T Laurencin
Journal:  Trends Biotechnol       Date:  2020-07-01       Impact factor: 19.536

4.  Bioprinted osteon-like scaffolds enhance in vivo neovascularization.

Authors:  Charlotte Piard; Hannah Baker; Timur Kamalitdinov; John Fisher
Journal:  Biofabrication       Date:  2019-03-28       Impact factor: 9.954

5.  Exosomes in disease and regeneration: biological functions, diagnostics, and beneficial effects.

Authors:  Yun Lin; Johnathon D Anderson; Lily M A Rahnama; Shenwen V Gu; Anne A Knowlton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-09-28       Impact factor: 4.733

Review 6.  Insights into inflammatory priming of mesenchymal stromal cells: functional biological impacts.

Authors:  Mehdi Najar; Mohammad Krayem; Makram Merimi; Arsène Burny; Nathalie Meuleman; Dominique Bron; Gordana Raicevic; Laurence Lagneaux
Journal:  Inflamm Res       Date:  2018-01-23       Impact factor: 4.575

7.  Isolation and identification of adipose-derived stromal/stem cells from breast cancer patients after exposure neoadjuvant chemotherapy.

Authors:  Ashleigh Rapp Hagaman; Ping Zhang; Kiavash R Koko; Ryan S Nolan; Marc W Fromer; John Gaughan; Martha Matthews
Journal:  World J Exp Med       Date:  2020-04-27

8.  Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017.

Authors:  Rachele Ciccocioppo; Claudia C Dos Santos; Daniel C Baumgart; Giuseppina C Cangemi; Vincenzo Cardinale; Carolina Ciacci; Paolo De Coppi; Debashis Haldar; Catherine Klersy; M Cristina Nostro; Michael Ott; Lorenzo Piemonti; Alice A Tomei; Basak Uygun; Stefania Vetrano; Giuseppe Orlando
Journal:  Cytotherapy       Date:  2018-02-15       Impact factor: 5.414

9.  Augmenting emergency granulopoiesis with CpG conditioned mesenchymal stromal cells in murine neutropenic sepsis.

Authors:  Julie Ng; Fei Guo; Anna E Marneth; Sailaja Ghanta; Min-Young Kwon; Joshua Keegan; Xiaoli Liu; Kyle T Wright; Baransel Kamaz; Laura A Cahill; Ann Mullally; Mark A Perrella; James A Lederer
Journal:  Blood Adv       Date:  2020-10-13

10.  Dose and duration of interferon γ pre-licensing interact with donor characteristics to influence the expression and function of indoleamine-2,3-dioxygenase in mesenchymal stromal cells.

Authors:  Devlin T Boyt; Lauren K Boland; Anthony J Burand; Alex J Brown; James A Ankrum
Journal:  J R Soc Interface       Date:  2020-06-17       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.